Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07006506
What this trial is testing

Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseGraft Vs Host DiseaseHematologic Malignancy
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT03925532
What this trial is testing

Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientOsteopeniaOsteoporosis
Roswell Park Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT01231412
What this trial is testing

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more
Fred Hutchinson Cancer Center 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT03597321
What this trial is testing

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 124
Testing effectiveness (Phase 2)Ended earlyNCT03218163
What this trial is testing

MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Post-approval studies (Phase 4)Looking for participantsNCT07569653
What this trial is testing

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus DiseaseHematopoietic Stem Cell Transplantation+1 more
WeiShi 120
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Large-scale testing (Phase 3)Study completedNCT02406144
What this trial is testing

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 316
Testing effectiveness (Phase 2)Study completedNCT03427866
What this trial is testing

Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.

Who this might be right for
Myelofibrosis
Massachusetts General Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT00675441
What this trial is testing

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

Who this might be right for
Graft-versus-Host Disease
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Ended earlyNCT00119366
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+14 more
Fred Hutchinson Cancer Center
Very early researchLooking for participantsNCT03378102
What this trial is testing

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Mari Dallas 20
Large-scale testing (Phase 3)Ended earlyNCT03391856
What this trial is testing

Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 15
Not applicableNot Yet RecruitingNCT07440654
What this trial is testing

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

Who this might be right for
aGVHD Prophylaxis
Nanfang Hospital, Southern Medical University 40
Not applicableStudy completedNCT06267898
What this trial is testing

Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML

Who this might be right for
MDSCMML
European Society for Blood and Marrow Transplantation 222
Early research (Phase 1)Ended earlyNCT02231710
What this trial is testing

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Who this might be right for
Primary Immune Deficiency DisordersHemophagocytic LymphohistiocytosisInherited Bone Marrow Failure Syndrome+2 more
Bellicum Pharmaceuticals 1
Not applicableNot Yet RecruitingNCT07328724
What this trial is testing

Critical Illness After Hematopoietic Cell Transplantation

Who this might be right for
Critical IllnessVentilated PatientsHematopoetic Stem Cell Transplantation+1 more
Peking University People's Hospital 4,000
Testing effectiveness (Phase 2)Ended earlyNCT02614560
What this trial is testing

Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

Who this might be right for
Acute Myeloid Leukemia
Seagen Inc. 14
Next Page
18